Introduction of the main addition and revision of the Chinese Pharmacopoeia 2025 Edition(Volume Ⅱ)
10.19778/j.chp.2025.01.004
- VernacularTitle:2025年版《中国药典》二部主要增修订内容解读
- Author:
ZHOU Yi
;
WANG Zhijun
;
YUE Zhihua
;
CHENG Qilei
;
YUE Ruiqi
;
YANG Xi
;
GUO Wei
;
MA Shuangcheng
- Publication Type:Journal Article
- Keywords:
The Chinese Pharmacopoeia 2025 Edition (Volume Ⅱ) (ChP 2025,Volume Ⅱ);
the addition and revision of drug monographs;
drug standard
- From:
Drug Standards of China
2025;26(1):023-027
- CountryChina
- Language:Chinese
-
Abstract:
The Pharmacopeia of the People’s Republic of China 2025 Edition (referred to as the Chinese Pharmacopoeia 2025 Edition, ChP 2025) will be promulgated and implemented. This article introduces the process of development of ChP 2025 Edition (Volume Ⅱ), including the selection, the revision of general notices,the addition and revision of drug monographs, etc., and provides some analysis and examples to illustrate,which can facilitate the readers to understand and implement the ChP 2025 Edition (Volume Ⅱ).
- Full text:202503111314503508120250204.pdf
